|
491 |
IgG Fc galactosylation predicts response to methotrexate in early rheumatoid arthritis
Enthalten in Arthritis Research & Therapy Bd. 19, 9.8.2017, Nr. 1, date:12.2017: 1-11
|
|
|
|
492 |
IL-1 family cytokines and soluble receptors in systemic lupus erythematosus
Enthalten in Arthritis Research & Therapy Bd. 20, 8.2.2018, Nr. 1, date:12.2018: 1-10
|
|
|
|
493 |
Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapies
Enthalten in Arthritis Research & Therapy Bd. 18, 20.12.2016, Nr. 1, date:12.2016: 1-11
|
|
|
|
494 |
Immunohistochemistry of sarcolemmal membrane-associated proteins in formalin-fixed and paraffin-embedded skeletal muscle tissue: a promising tool for the diagnostic evaluation of common muscular dystrophies
Enthalten in Diagnostic pathology Bd. 12, 20.2.2017, Nr. 1, date:12.2017: 1-10
|
|
|
|
495 |
Immunoselected STRO-3+ mesenchymal precursor cells reduce inflammation and improve clinical outcomes in a large animal model of monoarthritis
Enthalten in Stem cell research & therapy Bd. 8, 7.2.2017, Nr. 1, date:12.2017: 1-13
|
|
|
|
496 |
Impact of disease activity on health-related quality of life in systemic lupus erythematosus – a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS)
Enthalten in BMC immunology Bd. 18, 28.3.2017, Nr. 1, date:12.2017: 1-9
|
|
|
|
497 |
Impact of gastrointestinal events on patient-reported outcomes in Asia-Pacific women with osteoporosis: baseline results of the MUSIC OS-AP study
Enthalten in Archives of osteoporosis Bd. 12, 17.7.2017, Nr. 1, date:12.2017: 1-9
|
|
|
|
498 |
Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis
Enthalten in Arthritis Research & Therapy Bd. 19, 19.7.2017, Nr. 1, date:12.2017: 1-8
|
|
|
|
499 |
Impact of poor muscle strength on clinical and service outcomes of older people during both acute illness and after recovery
Enthalten in BMC geriatrics Bd. 17, 7.6.2017, Nr. 1, date:12.2017: 1-7
|
|
|
|
500 |
Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry
Enthalten in Clinical rheumatology Bd. 36, 7.3.2017, Nr. 4, date:4.2017: 895-901
|
|
Administration
